Skip to menu Skip to content Skip to footer

2000

Conference Publication

Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.

Mollee, P, Morton, J, Irving, I and Durrant, S (2000). Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD..

Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.

2000

Conference Publication

A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML)

Mollee, P., Taylor, K., Arthur, C., Wright, S. and Morton, J. (2000). A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML). 2nd Annual Scientific Meeting of the Haematology Society of Australia and New Zealand, Perth, WA, 25-28 July 2000. Washington, D.C.: American Society of Hematology.

A phase II study of interferon alpha (IFN) and intermittent oral cytarabine (YNK01) in the treatment of newly diagnosed chronic myeloid leukemia (CML)

2000

Conference Publication

A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.

Mollee, P., Taylor, K., Arthur, C., Wright, S., Rodwell, R. and Taylor, D. (2000). A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.. Perth, July 2000. Sydney: Haematology Society of Australia and New Zealand.

A Phase II study of Interferon alpha and intermittent oral Cytarabine in the treatment of newly diagnosed Chronic Myeloid Leukaemia.

1999

Journal Article

Long-term molecular remission in promyelocytic transformation of myeloproliferative disease

Mollee, P. N., Taylor, K. M., Williams, B., Taylor, D. and Rodwell, R. (1999). Long-term molecular remission in promyelocytic transformation of myeloproliferative disease. Leukemia, 13 (4), 648-650. doi: 10.1038/sj.leu.2401358

Long-term molecular remission in promyelocytic transformation of myeloproliferative disease

1999

Journal Article

Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor

Morton, J, Mollee, P, Taylor, K, Grigg, A, Durrant, S, Moore, D, Rodwell, R, Eliadis, P, Hutchins, C, Williams, B, Seeley, G, Wright, S, Kelly, C, Rentoul, A, Iland, H, Atkinson, K, Januszewicz, H, Bunce, I, Bashford, J, Stewart, C and Taylor, D (1999). Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor. Leukemia Research, 23 (2), 177-183. doi: 10.1016/S0145-2126(98)00143-X

Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor

1997

Journal Article

Promyelocytic transformation of polycythaemia vera (PV)

Mollee, P. N., Taylor, K. M. and Williams, B. (1997). Promyelocytic transformation of polycythaemia vera (PV). Australian and New Zealand journal of medicine, 27 (6), 709-710. doi: 10.1111/j.1445-5994.1997.tb01007.x

Promyelocytic transformation of polycythaemia vera (PV)